Novel Diagnostic and Therapeutical Opportunities for Asthma and Allergy
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Clinical Medicine, Cell, and Organism Physiology".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 1195
Special Issue Editors
2. Personalized Medicine, Asthma and Allergy, IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy
Interests: chronic rhinosinusitis; nasal polyps; monoclonal antibodies; type 2 inflammation; asthma; allergen immunotherapy; rhinitis
Special Issues, Collections and Topics in MDPI journals
2. IRCCS Humanitas Research Hospital, 20089 Rozzano, Italy
Interests: allergy; anaphylaxis; drug allergy; asthma; severe asthma; rhinosinusitis with and without nasal polyps; biologicals; precision medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The management of allergies and, in particular, asthma has changed considerably since the advent of novel diagnostic and therapeutical opportunities. The therapeutic vision was modified from a “one size fits all” approach to an increased attention to tailored treatment strategies for patients affected by specific disease phenotypes to both reduce side effects and increase the therapeutic effect. This allowed for achieving more satisfactory clinical results and complete control of the diseases in an increasingly high proportion of allergic diseases. This novel personalized approach to allergic diseases requires a careful study of the endotype and phenotype in each single patient, with a multidisciplinary vision and increasingly sensitive biomarkers, with the need for more resources in terms of research, diagnostic time, and tools. The modern specialist's challenge is to achieve the maximum benefit for the patient with the minimum expense related to obtaining it. This Issue will collect articles on allergic diseases management and treatment, with particular attention to respiratory diseases considering the aspects described above.
Dr. Giovanni Paoletti
Dr. Enrico Marco Heffler
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- allergy
- asthma
- severe asthma
- precision medicine
- multidisciplinary approach
- tailored treatment
